C16H24N4O
Neat
288.40
101954-20-5; Emedastine EP Impurity E; CHEMBL274747; 4-(1-(2-Ethoxyethyl)-1H-benzimidazol-2-yl)[1, 4]diazepane; 2-(1, 4-Diazepan-1-yl)-1-(2-ethoxyethyl)-1H-benzo[d]imidazole; P753J93M9U; 1-(2-ethoxyethyl)-2-(hexahydro-1H-1, 4-diazepin-1-yl)-1H-benzimidazole; 2-(1, 4-diazepan-1-yl)-1-(2-ethoxyethyl)benzimidazole; 4-(1-(2-Ethoxyethyl)-1H-benzimidazol-2-yl)(1, 4)diazepane; 1H-Benzimidazole, 1-(2-ethoxyethyl)-2-(hexahydro-1H-1, 4-diazepin-1-yl)-; Emedastine impurity E; UNII-P753J93M9U; SCHEMBL6598243; KCCFLPBATGOEJM-UHFFFAOYSA-N; BDBM50019639; Emedastine difumarate impurity E [EP]; EMEDASTINE DIFUMARATE IMPURITY E [EP IMPURITY]; 2-[1 and 4]Diazepan-1-yl-1-(2-ethoxy-ethyl)-1H-benzoimidazole
2-(1 and 4-diazepan-1-yl)-1-(2-ethoxyethyl)benzimidazole
InChI=1S/C16H24N4O/c1-2-21-13-12-20-15-7-4-3-6-14(15)18-16(20)19-10-5-8-17-9-11-19/h3-4,6-7,17H,2,5,8-13H2,1H3